Dr. Olga Chervyakova

Olga Chervyakova—Deputy Director General for science and commercialization, candidate of biological sciences, professor. Chervyakova is a specialist in the fields of molecular biology, genetic engineering, as well as veterinary mycology and virology. During the period of work, she made great advances in the implementation of republican and international scientific and technical programs/projects related to the development of tools and methods of diagnosis and prevention and the study of genomes of causative agents of human, livestock, and especially avian dangerous infections. She is the developer of the Kazakhstan coronavirus COVID-19 vaccine, including the inactivated vaccine QazCovid-in (QazVac). Chervyakova has co-authored more than 150 scientific papers, including 23 publications in international peer-reviewed scientific journals indexed in the databases of Clarivate Analytics (Web of Science) and Scopus, included in the 1–4 quarters according to the Journal Citation Reports of Clarivate Analytics or belonging to the 14th to 95th base Scopus indicators percentile on CiteScore. In 2012, O. Chervyakova became an award winner of the First President of the Republic of Kazakhstan—the Leader of the Nation Fund in the field of science and technology for the work “Development of technologies for improvement, preclinical, clinical studies and registration of the first domestic pandemic influenza A/H1N1 vaccine”.